POPULATION PHARMACOKINETIC ANALYSIS OF RILZABRUTINIB IN HEALTHY SUBJECTS AND PATIENTS WITH PEMPHIGUS.

被引：0
|
作者：
Ge, S. [1 ]
Li, M. [1 ]
Lu, Q. [1 ]
Katragadda, S. [1 ]
机构：
[1] Sanofi, Bridgewater, NJ USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2023年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
EP-019
引用
收藏
页码：S96 / S96
页数：1
相关论文
共 50 条
  • [41] Population Pharmacokinetic Model for Cancer Chemoprevention With Sulindac in Healthy Subjects
    Berg, Alexander K.
    Mandrekar, Sumithra J.
    Ziegler, Katie L. Allen
    Carlson, Elsa C.
    Szabo, Eva
    Ames, Mathew M.
    Boring, Daniel
    Limburg, Paul J.
    Reid, Joel M.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (04): : 403 - 412
  • [42] Population pharmacokinetic modelling of febuxostat in healthy subjects and people with gout
    Kamel, Bishoy
    Abuhelwa, Ahmad Y.
    Foster, David
    Duong, Janna K.
    Graham, Garry G.
    Williams, Kenneth M.
    Pile, Kevin D.
    Day, Richard O.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (12) : 5359 - 5368
  • [43] A Population Pharmacokinetic Analysis of Fimasartan, a Selective Angiotensin II Receptor Antagonist, in Healthy Caucasian Subjects and Korean Patients With Hypertension
    Lee, Howard
    Jang, In-Jin
    Yu, Kyung-Sang
    Choi, Jeongeun
    Oh, Byung-Hee
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2013, 2 (02): : 162 - 172
  • [44] Population Pharmacokinetic Analysis of Fevipiprant in Healthy Subjects and Asthma Patients using a Tukey's g-and-h Distribution
    Wang, Xinting
    Bartels, Christian
    Kulkarni, Swarupa
    Sangana, Ramachandra
    Jain, Monish
    Zack, Julia
    Yu, Jing
    DRUG RESEARCH, 2021, 71 (06) : 326 - 334
  • [45] Population pharmacokinetic analysis of ceftolozane/tazobactam in healthy volunteers and patients.
    Chandorkar, Gurudatt
    Mouksassi, Samer
    Hershberger, Ellie
    Krishna, Gopal
    PHARMACOTHERAPY, 2013, 33 (10): : E218 - E218
  • [46] Population Pharmacokinetic and Pharmacodynamic Analysis of Polmacoxib in Healthy Volunteers and Patients With Osteoarthritis
    Cho, Yong-Soon
    Bae, Kyun-Seop
    Choi, Seung Chan
    Cho, Joong Myung
    Lim, Hyeong-Seok
    CLINICAL THERAPEUTICS, 2022, 44 (01) : 67 - +
  • [47] Comparison of two population pharmacokinetic models characterizing letermovir pharmacokinetics separately in healthy subjects and patients
    Fancourt, Craig
    Cho, Carolyn
    Viberg, Anders
    Prohn, Marita
    Dykstra, Kevin
    Macha, Sreeraj
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S130 - S130
  • [48] Population pharmacokinetic analysis of ulotaront in subjects with schizophrenia
    Galluppi, Gerald R.
    Polhamus, Daniel G.
    Fisher, Jeannine M.
    Hopkins, Seth C.
    Koblan, Kenneth S.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2021, 10 (10): : 1245 - 1254
  • [49] Population Pharmacokinetic Meta-Analysis of Denosumab in Healthy Subjects and Postmenopausal Women with Osteopenia or Osteoporosis
    Liviawati Sutjandra
    Rachelle D. Rodriguez
    Sameer Doshi
    Mark Ma
    Mark C. Peterson
    Graham R. Jang
    Andrew T. Chow
    Juan José Pérez-Ruixo
    Clinical Pharmacokinetics, 2011, 50 : 793 - 807
  • [50] Population Pharmacokinetic Meta-Analysis of Denosumab in Healthy Subjects and Postmenopausal Women with Osteopenia or Osteoporosis
    Sutjandra, Liviawati
    Rodriguez, Rachelle D.
    Doshi, Sameer
    Ma, Mark
    Peterson, Mark C.
    Jang, Graham R.
    Chow, Andrew T.
    Jose Perez-Ruixo, Juan
    CLINICAL PHARMACOKINETICS, 2011, 50 (12) : 793 - 807
12345